RobertMDeanMD

Hematologic Oncology

Staff, Cleveland Clinic Taussig Cancer Institute | Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Join to view full profile

Dr. Dean is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dean's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 800-223-2273

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2000 - 2005
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2000
Boston University Medical CenterResidency, Internal Medicine, 1996 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1996

Certifications & Licensure

OH State Medical License 2005 - 2025
MA State Medical License 1998 - 2005
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Publications & Presentations

PubMed

61 citations
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies
Brian J. Bolwell, Brad Pohlman, Lisa Rybicki, Ronald Sobecks, Robert M. Dean
Bone Marrow Transplantation. 2007-07-09
183 citations
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
Jennifer N. Brudno, Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose
Nature Medicine. 2020-01-20
157 citations
NCCN guidelines ® insights hodgkin lymphoma, version 1.2018 featured updates to the NCCN guidelines
Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai, Richard F. Ambinder, Patricia Aoun
Journal of the National Comprehensive Cancer Network. 2018-03-01

Journal Articles

Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation
Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
Neutropenic Fever During Peripheral Blood Progenitor Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Increased Apheresis Collection Days
Mat Kalaycio, Robert Dean, Jack Khouri, Brad Pohlman, Aleksandr Lazaryan, Edward Copelan, Steven Andresen, Ronald Sobecks, Hien Liu, Journal of Clinical Apheresis

Abstracts/Posters

Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Impact of Clinical Versus Biochemical Progression on Post-Progression Survival in Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018